Is OCGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OCGN. It does not provide personalized investment advice.

OCGN (Ocugen, Inc. Common Stock) Stock Analysis - Financials

Ocugen, Inc. Common Stock (OCGN) is a publicly traded Healthcare sector company. As of October 25, 2026, OCGN trades at $0.74 with a market cap of $250.84M and a P/E ratio of 0.00. OCGN moved -6.72% today. Year to date, OCGN is -46.40%; over the trailing twelve months it is -51.65%. Its 52-week range spans $0.52 to $2.73. Analyst consensus is strong buy with an average price target of $10.20. Rallies surfaces OCGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are OCGN's key financials?

OCGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OCGN recently traded at $0.74. Market cap is $250.84M. P/E ratio is 0.00. Revenue is $4.58M.

OCGN Key Metrics

Key financial metrics for OCGN
Metric	Value
Price	$0.74
Market Cap	$250.84M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$2.73
52-Week Low	$0.52
Volume	8.05M
Avg Volume	0
Revenue (TTM)	$4.58M
Net Income	$-81.81M
Gross Margin	0.00%

OCGN Analyst Consensus

5 analysts cover OCGN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.20.

Common questions about OCGN

What are OCGN's key financials?: OCGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OCGN recently traded at $0.74. Market cap is $250.84M. P/E ratio is 0.00. Revenue is $4.58M.
Is OCGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OCGN. It does not provide personalized investment advice.